Cardigen Investment And Trading Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 21-06-2024
- Paid Up Capital ₹ 0.50 M
as on 21-06-2024
- Company Age 31 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 63.11 Cr
as on 21-06-2024
- Satisfied Charges ₹ 13.00 Cr
as on 21-06-2024
- Revenue 134.60%
(FY 2022)
- Profit 1262.38%
(FY 2022)
- Ebitda -237.27%
(FY 2022)
- Net Worth 14.86%
(FY 2022)
- Total Assets 14.94%
(FY 2022)
About Cardigen Investment And Trading
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹63.11 Cr. The company has closed loans amounting to ₹13.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hemal Shete and Raju Shete serve as directors at the Company.
- CIN/LLPIN
U65990MH1993PTC072542
- Company No.
072542
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jun 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cardigen Investment And Trading?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemal Shete  | Director | 28-Jun-1993 | Current |
| Raju Shete | Director | 01-Feb-2002 | Current |
Financial Performance and Corporate Structure Insights of Cardigen Investment And Trading.
Cardigen Investment And Trading Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 134.6% increase. The company also saw a substantial improvement in profitability, with a 1262.38% increase in profit. The company's net worth Soared by an impressive increase of 14.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cardigen Investment And Trading?
In 2021, Cardigen Investment And Trading had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hem-Sil Trading And Manufacturing Private LimitedActive 42 years 3 monthsHemal Shete is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Dec 2020 | ₹9.90 Cr | Open |
Others Creation Date: 25 Sep 2019 | ₹20.00 Cr | Open |
Yes Bank Limited Creation Date: 21 Jun 2018 | ₹33.21 Cr | Open |
How Many Employees Work at Cardigen Investment And Trading?
Unlock and access historical data on people associated with Cardigen Investment And Trading, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cardigen Investment And Trading, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cardigen Investment And Trading's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
